Literature DB >> 2879991

Peptide T in treatment of AIDS.

L Wetterberg, B Alexius, J Sääf, A Sönnerborg, S Britton, C Pert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2879991     DOI： 10.1016/s0140-6736(87)91989-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Peptide T does not ameliorate experimental autoimmune encephalomyelitis (EAE) in Lewis rats.

Authors:  I Sáez-Torres; C Espejo; J J Pérez; N Acarín; X Montalban; E M Martínez-Cáceres
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

2.  A proposed bioactive conformation of peptide T.

Authors:  N B Centeno; J J Perez
Journal:  J Comput Aided Mol Des       Date:  1998-01       Impact factor: 3.686

3.  Histopathological and immunohistochemical changes in psoriatic skin during peptide T treatment.

Authors:  T Talme; B L Rozell; K G Sundqvist; L Wetterberg; J A Marcusson
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 4.  Antiviral therapy in human immunodeficiency virus infection.

Authors:  E Sandström
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

Review 5.  The future of antiviral chemotherapy.

Authors:  S Crowe; J Mills
Journal:  Dermatol Clin       Date:  1988-10       Impact factor: 3.478
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.